FR3070494B1 - Methode de diagnostic d'une peau presentant des signes de vieillissement - Google Patents

Methode de diagnostic d'une peau presentant des signes de vieillissement Download PDF

Info

Publication number
FR3070494B1
FR3070494B1 FR1757817A FR1757817A FR3070494B1 FR 3070494 B1 FR3070494 B1 FR 3070494B1 FR 1757817 A FR1757817 A FR 1757817A FR 1757817 A FR1757817 A FR 1757817A FR 3070494 B1 FR3070494 B1 FR 3070494B1
Authority
FR
France
Prior art keywords
aging
diagnostic method
showing signs
skin showing
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1757817A
Other languages
English (en)
Other versions
FR3070494A1 (fr
Inventor
Sandra Kanani
Virginie Piffaut
Aude Foucher
Mark Donovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1757817A priority Critical patent/FR3070494B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to EP18756245.9A priority patent/EP3673270A1/fr
Priority to KR1020207008217A priority patent/KR102368508B1/ko
Priority to US16/638,878 priority patent/US20200363428A1/en
Priority to JP2020511320A priority patent/JP7062050B2/ja
Priority to PCT/EP2018/072569 priority patent/WO2019038290A1/fr
Publication of FR3070494A1 publication Critical patent/FR3070494A1/fr
Priority to JP2022016295A priority patent/JP2022069443A/ja
Application granted granted Critical
Publication of FR3070494B1 publication Critical patent/FR3070494B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
FR1757817A 2017-08-23 2017-08-23 Methode de diagnostic d'une peau presentant des signes de vieillissement Active FR3070494B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1757817A FR3070494B1 (fr) 2017-08-23 2017-08-23 Methode de diagnostic d'une peau presentant des signes de vieillissement
KR1020207008217A KR102368508B1 (ko) 2017-08-23 2018-08-21 노화 징후를 나타내는 피부의 진단 방법
US16/638,878 US20200363428A1 (en) 2017-08-23 2018-08-21 Diagnostic method of a skin showing signs of aging
JP2020511320A JP7062050B2 (ja) 2017-08-23 2018-08-21 老化の徴候を示す皮膚の診断方法
EP18756245.9A EP3673270A1 (fr) 2017-08-23 2018-08-21 Procédé de diagnostic d'une peau présentant des signes de vieillissement
PCT/EP2018/072569 WO2019038290A1 (fr) 2017-08-23 2018-08-21 Procédé de diagnostic d'une peau présentant des signes de vieillissement
JP2022016295A JP2022069443A (ja) 2017-08-23 2022-02-04 老化の徴候を示す皮膚の診断方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1757817 2017-08-23
FR1757817A FR3070494B1 (fr) 2017-08-23 2017-08-23 Methode de diagnostic d'une peau presentant des signes de vieillissement

Publications (2)

Publication Number Publication Date
FR3070494A1 FR3070494A1 (fr) 2019-03-01
FR3070494B1 true FR3070494B1 (fr) 2022-07-01

Family

ID=61655824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1757817A Active FR3070494B1 (fr) 2017-08-23 2017-08-23 Methode de diagnostic d'une peau presentant des signes de vieillissement

Country Status (6)

Country Link
US (1) US20200363428A1 (fr)
EP (1) EP3673270A1 (fr)
JP (2) JP7062050B2 (fr)
KR (1) KR102368508B1 (fr)
FR (1) FR3070494B1 (fr)
WO (1) WO2019038290A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11127176B2 (en) 2019-01-31 2021-09-21 L'oreal Systems and methods for visualizing future skin trends based on biomarker analysis
US11501356B2 (en) 2019-07-31 2022-11-15 L'oreal Systems and methods for generating personalized skincare formulations based on biomarker analysis
US11741523B2 (en) 2019-07-31 2023-08-29 L'oreal Personalized skincare recommendations based on biomarker analysis
FR3100452B1 (fr) * 2019-09-05 2021-09-17 Oreal Méthode de diagnostic de peaux agées

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667778B1 (fr) 1990-10-16 1995-05-12 Oreal Cellule permettant de collecter sur la peau, par circulation de liquide, au moins un compose a doser.
KR100961874B1 (ko) 2010-04-05 2010-06-09 주식회사 나노엔텍 외부동력 없이 유체가 이동하는 유체분석용 칩
EP2618808B1 (fr) * 2010-09-24 2016-09-21 L'Oréal Utilisation cosmétique de la dermcidine ou fragments de celle-ci
FR2968560A1 (fr) * 2010-12-13 2012-06-15 Oreal Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu
KR101507234B1 (ko) 2013-07-17 2015-03-31 로레알 생분자 추출기 및 생분자 추출방법

Also Published As

Publication number Publication date
KR20200041971A (ko) 2020-04-22
US20200363428A1 (en) 2020-11-19
JP2020531027A (ja) 2020-11-05
KR102368508B1 (ko) 2022-02-25
WO2019038290A1 (fr) 2019-02-28
FR3070494A1 (fr) 2019-03-01
JP2022069443A (ja) 2022-05-11
JP7062050B2 (ja) 2022-05-02
EP3673270A1 (fr) 2020-07-01

Similar Documents

Publication Publication Date Title
DK3285803T3 (da) Fremgangsmåder til behandling eller forebyggelse af migrænehovedpine
IT201700081018A1 (it) Trattamento di segnali elettrofisiologici
DK3206686T3 (da) Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
FR3022158B1 (fr) Catalyseur mesoporeux d'hydroconversion de residus et methode de preparation
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
EP3253445A4 (fr) Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère
FR3070494B1 (fr) Methode de diagnostic d'une peau presentant des signes de vieillissement
DK3157531T3 (da) Fremgangsmåder og sammensætninger til stimulering af det intestinale enteroendokrinesystem til behandling af sygdomme eller tilstande relateret hertil
MA43134A (fr) Compositions et méthodes de transduction tumorale
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3294142T3 (da) System og fremgangsmåde af biologiske vævsstrukturer
DK3565542T3 (da) Polymorphic forms of rad1901-2hcl
FR3055905B1 (fr) Methode de sexage precoce d'esturgeon
DK3377094T3 (da) Virulenssvækkede bakterier til behandling af ondartede solide tumorer
FR3037803B1 (fr) Implant de substitution du sternum
DK3374495T3 (da) Forbedrede fremgangsmåder til vævsfremstilling
DK3302523T3 (da) Sammensætning til behandling af vævslæsioner
IT201700115493A1 (it) Apparecchiatura e metodo per la sterilizzazione di endoscopi
DK3274005T3 (da) Fremgangsmåde til rekonstruktion af hud
GB201611413D0 (en) Method of skin care
IT201700013599A1 (it) Composizione farmaceutica per la prevenzione e il trattamento dei deficit mnestici e cognitivi correlati all’invecchiamento
FR3035458B1 (fr) Capuchon de fixation rotule
FR3029193B1 (fr) Micro-station d'epuration biologique
DK3364975T3 (da) Kombination af trazodon og gabapentin til behandling af smerter
DK3334425T3 (da) Methods of treatment or prevention of acute brain or nerve injuries

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190301

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8